196 related articles for article (PubMed ID: 7706296)
1. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes.
Toyoda H; Komurasaki T; Uchida D; Takayama Y; Isobe T; Okuyama T; Hanada K
J Biol Chem; 1995 Mar; 270(13):7495-500. PubMed ID: 7706296
[TBL] [Abstract][Full Text] [Related]
2. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.
Taylor DS; Cheng X; Pawlowski JE; Wallace AR; Ferrer P; Molloy CJ
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1633-8. PubMed ID: 9990076
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.
Watanabe T; Shintani A; Nakata M; Shing Y; Folkman J; Igarashi K; Sasada R
J Biol Chem; 1994 Apr; 269(13):9966-73. PubMed ID: 8144591
[TBL] [Abstract][Full Text] [Related]
4. Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor.
Sasaki E; Arakawa T; Fujiwara Y; Kawada N; Fukuda T; Higuchi K; Komurasaki T; Kobayashi K
Eur J Pharmacol; 1997 Nov; 338(3):253-8. PubMed ID: 9424019
[TBL] [Abstract][Full Text] [Related]
5. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.
Higashiyama S; Abraham JA; Miller J; Fiddes JC; Klagsbrun M
Science; 1991 Feb; 251(4996):936-9. PubMed ID: 1840698
[TBL] [Abstract][Full Text] [Related]
6. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
7. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus.
Parries G; Chen K; Misono KS; Cohen S
J Biol Chem; 1995 Nov; 270(46):27954-60. PubMed ID: 7499272
[TBL] [Abstract][Full Text] [Related]
8. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes.
Shirakata Y; Komurasaki T; Toyoda H; Hanakawa Y; Yamasaki K; Tokumaru S; Sayama K; Hashimoto K
J Biol Chem; 2000 Feb; 275(8):5748-53. PubMed ID: 10681561
[TBL] [Abstract][Full Text] [Related]
9. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
Komurasaki T; Toyoda H; Uchida D; Morimoto S
Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes.
Komurasaki T; Toyoda H; Uchida D; Nemoto N
Growth Factors; 2002 Jun; 20(2):61-9. PubMed ID: 12148564
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of a unique mitogenic activity secreted by rat Sertoli cells.
Lamb DJ; Spotts GS; Shubhada S; Baker KR
Mol Cell Endocrinol; 1991 Aug; 79(1-3):1-12. PubMed ID: 1936536
[TBL] [Abstract][Full Text] [Related]
12. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family.
Toyoda H; Komurasaki T; Uchida D; Morimoto S
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):69-75. PubMed ID: 9337852
[TBL] [Abstract][Full Text] [Related]
13. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
14. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
[TBL] [Abstract][Full Text] [Related]
15. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein.
Higashiyama S; Lau K; Besner GE; Abraham JA; Klagsbrun M
J Biol Chem; 1992 Mar; 267(9):6205-12. PubMed ID: 1556128
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development.
Toyoda H; Komurasaki T; Ikeda Y; Yoshimoto M; Morimoto S
FEBS Lett; 1995 Dec; 377(3):403-7. PubMed ID: 8549764
[TBL] [Abstract][Full Text] [Related]
17. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
Marikovsky M; Breuing K; Liu PY; Eriksson E; Higashiyama S; Farber P; Abraham J; Klagsbrun M
Proc Natl Acad Sci U S A; 1993 May; 90(9):3889-93. PubMed ID: 8483908
[TBL] [Abstract][Full Text] [Related]
18. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of epidermal growth factor binding to mouse cultured cells by fibroblast-derived growth factor. Evidence for an indirect mechanism.
Rozengurt E; Collins M; Brown KD; Pettican P
J Biol Chem; 1982 Apr; 257(7):3680-6. PubMed ID: 6277944
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF).
Shin SY; Shimizu M; Ohtaki T; Munekata E
Peptides; 1995; 16(2):205-10. PubMed ID: 7784250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
